Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DTC Ad Regulation Could Be WLF's Next Constitutional Challenge

Executive Summary

The Washington Legal Foundation is beginning to apply the same constitutional scrutiny it applied to off-label promotions to direct-to-consumer advertising.

You may also be interested in...



FDA Ad Division Deputy Director Abrams To Lead Division; Drezin Retires

FDA Division of Drug Marketing, Advertising and Communications Acting Deputy Director Tom Abrams will lead the division as acting director following the Jan. 31 retirement of Norm Drezin.

FDA Ad Division Deputy Director Abrams To Lead Division; Drezin Retires

FDA Division of Drug Marketing, Advertising and Communications Acting Deputy Director Tom Abrams will lead the division as acting director following the Jan. 31 retirement of Norm Drezin.

WLF Ruling Offers No Viable Alternatives For Encouraging sNDAs - FDA Appeal

The ruling overturning FDA's regulation of off-label reprint dissemination offers no viable alternatives for encouraging companies to file supplemental new drug applications, FDA's appeal of Washington Legal Foundation v. Henney argues.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS034998

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel